Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins
/in HIV/AIDS, International Publications /von 2005-11-01 / Blood 2006 Mar;107(5):1818-27Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma
/in International Publications, Malignant Melanoma /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3741-6Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity
/in International Publications, Malignant Melanoma /von 2005-11-01 / Clin. Cancer Res. 2005 Nov;11(21):7692-9Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6A):3709-14Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2005-11-01 / Anticancer Res. 2005 Nov-Dec;25(6B):4225-30Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
/in Hyperthermia, International Publications, Prostate Cancer /von 2005-11-01 / Int J Hyperthermia 2005 Nov;21(7):649-56Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection
/in Chronic Virus Hepatitis, International Publications /von 2005-11-01 / Clin. Exp. Immunol. 2005 Nov;142(2):362-9Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells
/in Colorectal Cancer, International Publications /von 2005-11-01 / Clin. Cancer Res. 2005 Nov;11(21):7891-900Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells
/in Colorectal Cancer, International Publications /von 2005-11-01 / Mol. Ther. 2005 Nov;12(5):950-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution